Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 121 | FOXA | FOX CORP | Communication Services | 28,224.0 | $1.5M | 0.34% | NEW | — | $52.16 | +32.3% |
| 122 | PLTR | PALANTIR TECHNOLOGIES INC | Technology | 12,594.0 | $1.5M | 0.34% | +1K | +10.0% | $116.67 | +47.0% |
| 123 | AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | 39,473.0 | $1.5M | 0.34% | +9K | +27.5% | $37.11 | -7.3% |
| 124 | BKR | BAKER HUGHES COMPANY | Energy | 26,356.0 | $1.5M | 0.34% | -7K | -21.5% | $55.50 | +16.1% |
| 125 | RYTM | RHYTHM PHARMACEUTICALS INC | Healthcare | 13,158.0 | $1.5M | 0.34% | +6K | +77.0% | $111.03 | +3.8% |
| 126 | CVNA | CARVANA CO | Consumer Cyclical | 22,152.0 | $1.5M | 0.34% | +18K | +457.7% | $65.82 | -1.2% |
| 127 | NEM | NEWMONT CORP | Basic Materials | 15,528.0 | $1.5M | 0.34% | +586.0 | +3.9% | $93.40 | +24.2% |
| 128 | LGND | LIGAND PHARMACEUTICALS INC | Healthcare | 4,551.0 | $1.4M | 0.34% | +98.0 | +2.2% | $316.09 | -9.0% |
| 129 | — | IMMUNITYBIO INC | — | 163,786.0 | $1.4M | 0.33% | -194K | -54.2% | $8.76 | — |
| 130 | — | KINIKSA PHARMACEUTICALS INTL | — | 22,411.0 | $1.4M | 0.33% | +2K | +10.4% | $63.95 | — |
| 131 | — | ASCENDIS PHARMA A/S | — | 5,333.0 | $1.4M | 0.33% | NEW | — | $266.72 | — |
| 132 | CYTK | CYTOKINETICS INC | Healthcare | 16,577.0 | $1.4M | 0.33% | +12K | +285.2% | $85.19 | -10.7% |
| 133 | CME | CME GROUP INC | Financial Services | 6,394.0 | $1.4M | 0.33% | -277.0 | -4.2% | $220.83 | +23.0% |
| 134 | KURA | KURA ONCOLOGY INC | Healthcare | 128,495.0 | $1.4M | 0.33% | +46K | +55.5% | $10.97 | +12.4% |
| 135 | ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | 55,139.0 | $1.4M | 0.33% | +24K | +77.3% | $25.30 | +19.3% |
| 136 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 63,720.0 | $1.4M | 0.33% | +22K | +53.8% | $21.86 | -8.9% |
| 137 | RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | 35,400.0 | $1.4M | 0.32% | +29K | +429.5% | $39.12 | +11.5% |
| 138 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 53,688.0 | $1.4M | 0.32% | +39K | +254.0% | $25.72 | -5.5% |
| 139 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 11,705.0 | $1.4M | 0.32% | -1K | -9.9% | $117.07 | -13.8% |
| 140 | ROIV | ROIVANT SCIENCES LTD | Healthcare | 38,711.0 | $1.4M | 0.32% | +509.0 | +1.3% | $35.39 | +5.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
36.7%
Technology
15.7%
Financial Services
15.3%
Industrials
13.0%
Consumer Cyclical
5.8%
Energy
4.7%
Real Estate
2.8%
Utilities
1.7%
Communication Services
1.7%
Basic Materials
1.5%